Treatment with Vitamin D for those with low levels of Vitamin D reduced the risk of asthma attacks and the hospitalizations associated with it.
Highlights
- Supplementing vitamin D with the standard asthma treatment can reduce the risk of asthma attacks.
- Vitamin D boosts immune responses to respiratory viruses which trigger symptoms of asthma.
- The protective effect of vitamin D supplementation is strongest in participants with low blood vitamin D concentrations.
For the study, data from 955 participants in seven randomised controlled trials, which tested the use of vitamin D supplements were collected and analyzed.
Vitamin D Supplements For Asthma
Vitamin D supplementation resulted in:
Lead researcher Professor Adrian Martineau said, "These results add to the ever growing body of evidence that vitamin D can support immune function as well as bone health. On average, three people in the UK die from asthma attacks every day. Vitamin D is safe to take and relatively inexpensive so supplementation represents a potentially cost-effective strategy to reduce this problem."
The team’s use of individual participant data also allowed them to query the extent to which different groups respond to vitamin D supplementation, in more detail than previous studies.
However, due to relatively small numbers of patients within sub-groups, the researchers caution that they did not find definitive evidence to show that effects of vitamin D supplementation differ according to baseline vitamin D status.
Professor Hywel Williams, Director of the NIHR Health Technology Assessment Programme, said: "The results of this NIHR-funded study brings together evidence from several other studies from over the world and is an important contribution to reducing uncertainties on whether Vitamin D is helpful for asthma - a common condition that impacts on many thousands of people worldwide."
Dr David Jolliffe from QMUL, first author on the paper, added: "Our results are largely based on data from adults with mild to moderate asthma: children and adults with severe asthma were relatively under-represented in the dataset, so our findings cannot necessarily be generalised to these patient groups at this stage. Further clinical trials are on-going internationally, and we hope to include data from them in a future analysis to determine whether the promise of today’s results is confirmed in an even larger and more diverse group of patients."
Reference
- Richard Beasley and Mark Weatherall. Vitamin D and asthma: a case to answer, Lancet Respiratory Medicinehttp://dx.doi.org/10.1016/S2213-2600(17)30346-6.
Source-Medindia